Skip to main content
Full access
Datapoints
Published Online: 20 November 2018

Mental Disorders Among Children Born With Neonatal Abstinence Syndrome

Despite high incidence of neonatal abstinence syndrome (NAS) (1), a drug withdrawal condition resulting from in utero opioid exposure, there are limited longitudinal data regarding children’s outcomes (2). This study extends previous work by examining psychiatric outcomes in early childhood for a sample of Medicaid-covered infants with NAS compared with all other births.
Using claims from Truven Health Analytics’ Multi-State Medicaid Database, we used ICD-9 codes to identify infant livebirth (codes V30-V39) records from January 2008 through September 2010 with 5 years of continuous enrollment and a diagnosis of NAS (code 779.5, N=1,046) and all other births (N=269,726) [see online supplement]. Outcomes were mental disorders diagnosed between ages 1 and 5 years (Chapter V codes, 290–319).
Approximately half of the children with NAS had a diagnosed mental disorder before age 5, compared with 30% of all other births (p<.05) (Table 1). Compared with all other births, children born with NAS were over twice as likely to have disturbance of conduct, hyperkinetic syndrome of childhood, adjustment reaction, and intellectual disabilities and were over 1.5 times more likely have specific delays in development and other disorders.
TABLE 1. Mental disorders among children born with NAS and all other birthsa
 NAS births (N=1,046)All other births (N=269,726) 
ICD-9 diagnostic category and code groupN%N%Z score
Any mental disorder51148.981,81430.312.996*
Specific delays in development (e.g., language, coordination) (315)32731.349,59118.410.719*
Disturbance of conduct (312)11310.810,8794.011.073*
Hyperkinetic syndrome of childhood (e.g., ADHD) (314)949.09,3723.59.687*
Adjustment reaction (309)757.27,7992.98.220*
Acute reaction to stress (308)494.78,1233.03.156*
Neurotic disorders (e.g., anxiety) (300)434.17,3652.72.731*
Special symptoms or syndromes (307)413.99,6723.6.579
Disturbance of emotions specific to childhood and adolescence (313)393.75,3502.04.033*
Intellectual disabilities (317–319)373.54,0741.55.351*
Psychoses with origin specific to childhood (e.g., autism spectrum, pervasive developmental disorders) (299)323.14,7521.83.179*
a
Diagnoses may co-occur. Prevalence of all other diagnostic code groups less than 1%. Source: Truven Health Analytics’ Multi-State Medicaid Database.
*
p<0.05
These findings demonstrate that NAS is a marker for high levels of risk of psychiatric conditions in early childhood. Because of environmental and other confounders, we are able to note only an association between NAS and mental disorders, not a causal relationship. Type of opiate or other substance exposure in utero and postnatal treatment likely contributed to the outcomes as well.

Acknowledgments

The authors thank the Assistant Secretary for Mental Health and Substance Use, Elinore McCance-Katz, for her support.

Supplementary Material

File (appi.ps.201800341.ds001.pdf)

References

1.
Winkelman TNA, Villapiano N, Kozhimannil KB, et al: Incidence and costs of neonatal abstinence syndrome among infants with Medicaid: 2004–2014. Pediatrics 2018;141:e20173520
2.
Reddy UM, Davis JM, Ren Z, et al: Opioid use in pregnancy, neonatal abstinence syndrome, and childhood outcomes: executive summary of a joint workshop by the Eunice Kennedy Shriver National Institute of Child Health and Human Development, American College of Obstetricians and Gynecologists, American Academy of Pediatrics, Society for Maternal-Fetal Medicine, Centers for Disease Control and Prevention, and the March of Dimes Foundation. Obstet Gynecol 2017; 130:10–28

Information & Authors

Information

Published In

Go to Psychiatric Services
Go to Psychiatric Services

Cover: XXXX

Psychiatric Services
Pages: 151
PubMed: 30453858

History

Received: 17 July 2018
Accepted: 24 August 2018
Published online: 20 November 2018
Published in print: February 01, 2019

Keywords

  1. Child psychiatry/developmental
  2. Neonatal Abstinence Syndrome

Authors

Details

Laura J. Sherman, Ph.D. [email protected]
Substance Abuse and Mental Health Services Administration, Rockville, Maryland. Amy M. Kilbourne, Ph.D., M.P.H., and Tami L. Mark, Ph.D., are editors of this column.
Mir M. Ali, Ph.D.
Substance Abuse and Mental Health Services Administration, Rockville, Maryland. Amy M. Kilbourne, Ph.D., M.P.H., and Tami L. Mark, Ph.D., are editors of this column.
Ryan Mutter, Ph.D.
Substance Abuse and Mental Health Services Administration, Rockville, Maryland. Amy M. Kilbourne, Ph.D., M.P.H., and Tami L. Mark, Ph.D., are editors of this column.
Justine Larson, M.D., M.P.H.
Substance Abuse and Mental Health Services Administration, Rockville, Maryland. Amy M. Kilbourne, Ph.D., M.P.H., and Tami L. Mark, Ph.D., are editors of this column.

Notes

Send correspondence to Dr. Sherman ([email protected]).

Funding Information

The authors report no financial relationships with commercial interests.

Metrics & Citations

Metrics

Citations

Export Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.

For more information or tips please see 'Downloading to a citation manager' in the Help menu.

Format
Citation style
Style
Copy to clipboard

View Options

View options

PDF/EPUB

View PDF/EPUB

Login options

Already a subscriber? Access your subscription through your login credentials or your institution for full access to this article.

Personal login Institutional Login Open Athens login
Purchase Options

Purchase this article to access the full text.

PPV Articles - Psychiatric Services

PPV Articles - Psychiatric Services

Not a subscriber?

Subscribe Now / Learn More

PsychiatryOnline subscription options offer access to the DSM-5-TR® library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.

Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).

Media

Figures

Other

Tables

Share

Share

Share article link

Share